Radiofrequency ablation eliminates nondysplastic BE

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 17 No 9
Volume 17
Issue 9

Radiofrequency ablation (RA) is effective for the complete eradication of nondysplastic Barrett’s esophagus (BE), according to researchers from the Academic Medical Center in Amsterdam.

ABSTRACT: Studies finds RA, with or without prior endoscopic resection, proves safe for removal of Barrett’s esophagus and associated neoplasia.

Radiofrequency ablation (RA) is effective for the complete eradication of nondysplastic Barrett’s esophagus (BE), according to researchers from the Academic Medical Center in Amsterdam.

 

Roos E. Pouw, MD, and colleagues enrolled 44 patients who had BE (median of 7 cm) with early neoplasia. Visible lesions were endoscopically resected. Circumferential and focal ablation was repeated every 2 months until the entire Barrett epithelium was eradicated (Journal of Gastrointestinal Surgery online, August 13, 2008).

 

Among 31 patients, 16 first underwent endoscopic resection for early cancer, 12 had high-grade dysplasia, and 3 displayed low-grade dysplasia. After resection, the worst remaining histology was high-grade in 32 cases, low-grade in 10 cases, and 2 without dysplasia.

 

Post-ablation, complete histological eradication of all dysplasia and intestinal metaplasia was achieved in 43 patients.

Recent Videos
Patients who respond to avutometinib/defactinib may be maintained on treatment for long periods of time, says Rachel N. Grisham, MD.
2 experts in this video
2 experts in this video
Treatment with lorlatinib might be effective regardless of the presence of central nervous system metastases, according to Misako Nagasaka, MD, PhD.
Most central nervous system events with lorlatinib were grade 1 or 2 in the phase 3 CROWN trial.
Related Content